Supriya Lifescience

Supriya Lifescience Limited is a well-known manufacturer of active pharmaceutical ingredients (APIs), starting as a partnership in 1985 before becoming a public limited company in 2008. The company demonstrates its commitment to creating sustainable value by consistently strengthening its business, ensuring long-term growth and stability for its stakeholders. It has broadbased its business model to deepen research, manufacture formulations, enter less-crowded markets, and fund capital expenditure from its own earnings. It offers a diverse product portfolio of 38 specialized APIs, including medicines for anti-histamines, analgesics, vitamins, anesthetics, and anti-asthmatics. The company possesses a government-approved R&D facility where it focuses on developing new products and enhancing existing ones and their drug delivery systems. A significant portion of its business is global, with 79% of its 2023-24 revenue generated from exports to markets like Europe and Asia.;